CopyMark Law Group
4.9/5
Drawing for OXITRAN

USPTO serial 87093137

OXITRAN

Reviewed by CopyMark Law Group

Reg. 5239739Status 710
Filing date
Status date
Registration date
Jul 11, 2017
Examiner
MARESCA, MEREDITH Z
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with OXITRAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maria A. Scungio

MARIA A. SCUNGIO LOCKE LORD LLPCHURCH STREET STATION; P.O. BOX 1470NEW YORK, NY 10008-1470UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Active chemical ingredients for use in the manufacture of small molecule pharmaceuticals for treating neuromuscular and ophthalmological diseases; reagents for scientific and medical research for use in the research of small molecule pharmaceuticals and research of the treatment of neuromuscular and ophthalmological diseases; all of the foregoing excluding cleaning agents for use in laboratories and industriesSECTION 8 - CANCELLED—
005Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of neuromuscular and ophthalmological diseases; Pharmaceutical preparations for the treatment of central nervous system-related conditions, neurological and muscular diseases, neuro-muscular diseases, muscular dystrophies, ataxias, amyotrophia, atrophy, ophthalmological diseases, muscle wasting, cardiomyopathies, optic nerve degradation, neurological indications, memory loss, Lou Gehrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneuropathies, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; reagents for medical use in connection with the aforementioned diseasesSECTION 8 - CANCELLED—
042Medical research; scientific research; medical and scientific research, namely, conducting clinical trials for others; computer programming for others for medical and science research purposes; scientific research for testing cell cultures and developing cellular test systems for evaluating new drugs and antibodies; developing test systems for detecting pharmacologically active compounds; genetic animal model testing and scientific research for neuro-muscular and ophthalmological diseases for research purposesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 26, 2024C8..CANCELLED SEC. 8 (6-YR)—
Jul 11, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 20, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 20, 2018COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 11, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 2, 2017DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jun 2, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 11, 2017IUCNNOTICE OF ALLOWANCE CANCELLED—
May 11, 2017EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
May 2, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 7, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 7, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 15, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 31, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 25, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 24, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 24, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 17, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 29, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 29, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 29, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 29, 2016ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Dec 23, 2016ALIEASSIGNED TO LIE—
Nov 17, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 17, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 17, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 1, 2016ALIEASSIGNED TO LIE—
Oct 26, 2016ALIEASSIGNED TO LIE—
Oct 18, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 18, 2016GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Oct 18, 2016GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Oct 18, 2016EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Oct 18, 2016CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Oct 13, 2016DOCKASSIGNED TO EXAMINER—
Jul 8, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 8, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance